Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Transplantation|July 4, 2001
Human monocytic ehrlichiosis: an emerging pathogen in transplantationH P Tan, J S Dumler, W R Maley, et al.
Journal of Hepatology|February 6, 2017
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antiviralsStacey B Prenner, Lisa B VanWagner, Steven L Flamm, et al.
Journal of Managed Care & Specialty Pharmacy|June 9, 2021
Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational studyMichael P Curry, Steven L Flamm, Scott Milligan, et al.
The American Journal of Managed Care|July 19, 2019
Changing demographics among populations prescribed HCV treatment, 2013-2017Naoky Tsai, Bruce Bacon, Michael Curry, et al.
The American Journal of Surgical Pathology|August 19, 2004
Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel diseaseStephen A Geller, Marla C Dubinsky, F Fred Poordad, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 13, 2021
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of TerlipressinSteven L Flamm, Kimberly Brown, Hani M Wadei, et al.
Advances in Therapy|July 29, 2022
Pharmacokinetic Assessment and Treatment Effect of Lusutrombopag in Child-Pugh Class C Patients: Review of Patient Data from Two Clinical Studies and Post-Marketing SurveillanceSteven L Flamm, Markus Peck-Radosavljevic, Takahiro Fukuhara, et al.
Advances in Therapy|April 13, 2020
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C InfectionSteven L Flamm, Jens Kort, Steven E Marx, et al.
Antiviral Therapy|February 19, 2016
On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trialTania M Welzel, K Rajender Reddy, Steven L Flamm, et al.
Gastroenterology|August 21, 2010
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rateMark S Sulkowski, Mitchell L Shiffman, Nezam H Afdhal, et al.
Pageof 7